Notes
2012 US dollars
Reference
Liu CY, et al. Cost-Effectiveness Analysis of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation in Taiwan. Clinical Drug Investigation : 17 Dec 2016. Available from: URL: http://doi.org/10.1007/s40261-016-0487-7
Rights and permissions
About this article
Cite this article
Apixaban most cost effective for stroke prevention in AF. PharmacoEcon Outcomes News 769, 3 (2017). https://doi.org/10.1007/s40274-017-3639-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3639-y